Clinical Trials Sponsored by Imagine for Margo

Total 362 results

University of Birmingham
Roche Pharma AG; Cancer Research UK; Imagine for Margo; EUSA Pharma, Inc.

Active, not recruiting

Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children (BEACON)

Neuroblastoma

France, Austria, Belgium, Denmark, Ireland, Italy, Spain, Switzerland, United Kingdom, Netherlands
Center for Diagnostic Imaging

Unknown

Evaluation of Stool Tagging for Improved Patient Compliance

Polyps | Colon Cancer

United States
Mario Negri Institute for Pharmacological Research

Not yet recruiting

1 vs 7 RATG Infusions in Renal Transplantation (ONSET)

Kidney Replacement

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

An Outcome Analysis of Primary Membranous Nephropathy (PROMENADE)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

New Analytic Tools for aHUS and C3G Diagnosis (COMPRare)

Healthy | Hemolytic-Uremic Syndrome | Membranoproliferative Glomerulonephritis

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care

Brain Injuries, Acute

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer (ATRA)

Breast Neoplasm Female

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Autoreactive B Cells in Membranous Nephropathy (PEPTIDE)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study. (CHECK)

Colorectal Neoplasms

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico)

Emergency Department | Evaluation | Quality of Care | Appropriateness

Italy
Mario Negri Institute for Pharmacological Research

Completed

Diadem to Investigate the Activity and Safety of Durvalumab (Diadem)

Pleura Mesothelioma

Italy
Mario Negri Institute for Pharmacological Research

Completed

Early CPAP in COVID-19 Patients With Respiratory Failure. (EC-COVID-RCT)

COVID-19 | Emergency Departments | CPAP Ventilation

Italy
Mario Negri Institute for Pharmacological Research

Completed

Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study. (EC-COVID-PCS)

Early CPAP Ventilation in COVID-19 Patients

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation (RAFTING)

Rheumatoid Arthritis

Italy
Mario Negri Institute for Pharmacological Research

Completed

Nephrolithiasis Prevention by Lemon Juice (LIMONE)

Nephrolithiasis

Italy
Mario Negri Institute for Pharmacological Research

Terminated

the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment (VICTOR3)

Triple Negative Breast Cancer

Spain, Italy, Portugal
Mario Negri Institute for Pharmacological Research

Completed

GREAT - Good Response With Appropriate Treatment

Neoplasms | Cancer Pain

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Italy
Mario Negri Institute for Pharmacological Research

Completed

Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)

Type 2 Diabetes

Italy, Slovenia
Mario Negri Institute for Pharmacological Research

Terminated

ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach) (ITACA-S2)

Gastric Adenocarcinoma

Italy
Mario Negri Institute for Pharmacological Research

Completed

CE-US in Renal Transplantation

Renal Transplantation

Italy
Mario Negri Institute for Pharmacological Research

Completed

Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study (ALADIN)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Italy
Mario Negri Institute for Pharmacological Research

Completed

Ezetimibe and Simvastatin in Dyslipidemia of Diabetes

Type 2 Diabetes

Italy
Mario Negri Institute for Pharmacological Research

Completed

L-Arginine in Pre-Eclampsia

Pre-Eclampsia

Italy
Mario Negri Institute for Pharmacological Research

Completed

Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation

Kidney Transplant

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

Kidney Perfusion With or Without Absorption (POWER)

Kidney Replacement

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome (BLINDER)

Nephrotic Syndrome

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Outcome of ADPKD With Octreotide LAR (ADPKD648)

Autosomal Dominant Polycystic Kidney

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy (aHUS-iPSC-EC)

Atypical Hemolytic Uremic Syndrome

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Acoustic Analysis of VA Sounds (VAsound)

End Stage Renal Disease | Hemodialysis Access Failure

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

CardioPulmonary Resuscitation With Argon (CPAr) Trial (CPAr)

Cardiac Arrest With Successful Resuscitation | Cardiac Arrest, Out-Of-Hospital

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Health-care Quality in Semi-intensive Care Units

Evaluation | Quality | Semi-intensive Care Unit

Italy
Mario Negri Institute for Pharmacological Research

Withdrawn

LSCI and Thermography in Diabetic Foot Patients Affected by Ulcer(s): (MY-FOOT-B) (MY-FOOT-B)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Ulcer Foot
Mario Negri Institute for Pharmacological Research

Terminated

CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma (CoQun)

Open Angle Glaucoma

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

NASCITA Italian Birth Cohort Study (NASCITA)

Mental Disorders | Communicable Diseases | Nutrition Disorders | Health Knowledge, Attitudes, Practice | Development, Child | Social Determinants of Health

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Genotype and Susceptibility to COVID-19 (ORIGIN)

Covid19

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) (Mon-Covid)

COVID-19

Italy
Mario Negri Institute for Pharmacological Research

Withdrawn

Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers (CIS/MSC08)

Acute Kidney Injury | Solid Tumors

Italy
Mario Negri Institute for Pharmacological Research

Completed

Sevelamer in Proteinuric CKD (ANSWER)

Chronic Kidney Disease

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Enzyme Replacement Therapy in Fabry Disease

Fabry Disease

Italy
Mario Negri Institute for Pharmacological Research

Completed

Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety (SIRENA)

Polycystic Kidney

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency (SIRENA-II)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Italy
Mario Negri Institute for Pharmacological Research

Completed

Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism (APPLE)

Renal Transplant | Secondary Hyperparathyroidism

Italy
Mario Negri Institute for Pharmacological Research

Completed

Statins in Proteinuric Nephropathies (ESPLANADE)

Hypertension | Proteinuria | Chronic Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases (ANTHEM)

Healthy | Autosomal Dominant Polycystic Kidney | Atypical Hemolytic Uremic Syndrome | Membranoproliferative Glomerulonephritis

Italy
Mario Negri Institute for Pharmacological Research

Not yet recruiting

Reduction Of Dietary Salt Intake To Control Systolic Blood Pressure In Hypertensive Older Patients (REPRESS)

Hypertension
Mario Negri Institute for Pharmacological Research

Recruiting

B Cells in Idiopathic Nephrotic Syndrome (BLADE)

Nephrotic Syndrome

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study (GOETH)

Stomach Neoplasms

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (ASST Papa Giovanni XXIII)

Emergency Departments | Evaluation | Quality of Care | Appropriateness

Italy
Mario Negri Institute for Pharmacological Research

Completed

Thyroid Hormones in ADPKD (REORIENTED)

Autosomal Dominant Polycystic Kidney

Italy

Clinical Trials Sponsored by Imagine for Margo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations